Literature DB >> 29122497

Further delineation of the phenotypic spectrum of ISCA2 defect: A report of ten new cases.

Majid Alfadhel1, Marwan Nashabat2, Muhammad Talal Alrifai3, Hesham Alshaalan4, Fuad Al Mutairi2, Saif A Al-Shahrani5, Barbara Plecko6, Rawan Almass7, Maysoon Alsagob7, Faten B Almutairi7, Ahmed Al-Rumayyan3, Waleed Al-Twaijri3, Mohammed Al-Owain5, Robert W Taylor8, Namik Kaya9.   

Abstract

Iron-Sulfur Cluster (ISC) biogenesis is a vital cellular process required to produce various ISC-containing proteins. These ISC proteins are responsible for essential functions such as glycine cleavage and the formation of lipoic acid, an essential cofactor of respiratory chain complexes. Defects in ISC biogenesis lead to multiple mitochondrial dysfunction syndromes including: ISCA2 with infantile onset leukodystrophy. Recently, a founder mutation, c.229G > A, p.Gly77Ser in ISCA2 was reported to cause Multiple Mitochondrial Dysfunction Syndrome type 4. In a retrospective review of children diagnosed with the ISCA2 defect, we were able to identify ten new patients who were not reported previously with the identical founder mutation. High CSF glycine levels and elevated glycine peaks on MR spectroscopy were demonstrated in all tested probands. All patients were between 3 and 7 months of age with a triad of neurodevelopmental regression, nystagmus and optic atrophy and leukodystrophy. MRI findings were typical in the patients with diffuse, abnormal white matter signal in the cerebrum, cerebellum, brain stem and spinal cord. The patients ended up in a vegetative state, and often premature death due to respiratory infections. We alert clinicians to consider the ISCA2 defect as a differential diagnosis of infantile onset leukodystrophies affecting the brain as well as the spinal cord, especially in the presence of elevated CSF glycine or elevated glycine peaks in MR spectroscopy.
Copyright © 2017 European Paediatric Neurology Society. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Hypotonia; ISCA2; Mitochondrial disease; Neurodevelopmental regression; White matter

Mesh:

Substances:

Year:  2017        PMID: 29122497     DOI: 10.1016/j.ejpn.2017.10.003

Source DB:  PubMed          Journal:  Eur J Paediatr Neurol        ISSN: 1090-3798            Impact factor:   3.140


  8 in total

1.  ISCA2 mutations manifest differentially from DARS2 mutations.

Authors:  Josef Finsterer; Sinda Zarrouk-Mahjoub
Journal:  Metab Brain Dis       Date:  2018-05-22       Impact factor: 3.584

Review 2.  Clinical 1H MRS in childhood neurometabolic diseases - part 2: MRS signatures.

Authors:  Matthew T Whitehead; Lillian M Lai; Stefan Blüml
Journal:  Neuroradiology       Date:  2022-02-28       Impact factor: 2.804

3.  The Leukodystrophy Spectrum in Saudi Arabia: Epidemiological, Clinical, Radiological, and Genetic Data.

Authors:  Majid Alfadhel; Mohammed Almuqbil; Fuad Al Mutairi; Muhammad Umair; Mohammed Almannai; Malak Alghamdi; Hamad Althiyab; Rayyan Albarakati; Fahad A Bashiri; Walaa Alshuaibi; Duaa Ba-Armah; Mohammed A Saleh; Ali Al-Asmari; Eissa Faqeih; Waleed Altuwaijri; Ahmed Al-Rumayyan; Mohammed Ali Balwi; Faroug Ababneh; Abdulrahman Faiz Alswaid; Wafaa M Eyaid; Naif A M Almontashiri; Amal Alhashem; Khalid Hundallah; Aida Bertoli-Avella; Peter Bauer; Christian Beetz; Muhammad Talal Alrifai; Ahmed Alfares; Brahim Tabarki
Journal:  Front Pediatr       Date:  2021-05-13       Impact factor: 3.418

Review 4.  Clinical and genetic aspects of defects in the mitochondrial iron-sulfur cluster synthesis pathway.

Authors:  A V Vanlander; R Van Coster
Journal:  J Biol Inorg Chem       Date:  2018-04-05       Impact factor: 3.358

Review 5.  Update Review about Metabolic Myopathies.

Authors:  Josef Finsterer
Journal:  Life (Basel)       Date:  2020-04-17

Review 6.  Molecular Basis of Rare Diseases Associated to the Maturation of Mitochondrial [4Fe-4S]-Containing Proteins.

Authors:  Francesca Camponeschi; Simone Ciofi-Baffoni; Vito Calderone; Lucia Banci
Journal:  Biomolecules       Date:  2022-07-21

Review 7.  Down the Iron Path: Mitochondrial Iron Homeostasis and Beyond.

Authors:  Jonathan V Dietz; Jennifer L Fox; Oleh Khalimonchuk
Journal:  Cells       Date:  2021-08-25       Impact factor: 6.600

8.  ZBTB11 dysfunction: spectrum of brain abnormalities, biochemical signature and cellular consequences.

Authors:  Dulika Sumathipala; Petter Strømme; Zohreh Fattahi; Torben Lüders; Ying Sheng; Kimia Kahrizi; Ingunn Holm Einarsen; Jennifer L Sloan; Hossein Najmabadi; Lambert van den Heuvel; Ron A Wevers; Sergio Guerrero-Castillo; Lars Mørkrid; Vassili Valayannopoulos; Paul Hoff Backe; Charles P Venditti; Clara D van Karnebeek; Hilde Nilsen; Eirik Frengen; Doriana Misceo
Journal:  Brain       Date:  2022-07-29       Impact factor: 15.255

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.